Osaic Holdings’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-562
Closed -$9.24K 7527
2023
Q4
$9.24K Sell
562
-790
-58% -$12.4K ﹤0.01% 5872
2023
Q3
$10.4K Buy
1,352
+395
+41% +$2.14K ﹤0.01% 5894
2023
Q2
$4.99K Buy
957
+246
+35% +$1.25K ﹤0.01% 6311
2023
Q1
$3.82K Sell
711
-1
-0.1% -$5 ﹤0.01% 6465
2022
Q4
$3.09K Buy
712
+514
+260% +$2.27K ﹤0.01% 6469
2022
Q3
$1K Hold
198
﹤0.01% 7142
2022
Q2
$1K Hold
198
﹤0.01% 7207
2022
Q1
$1K Hold
198
﹤0.01% 7153
2021
Q4
$3K Hold
198
﹤0.01% 6939
2021
Q3
$4K Sell
198
-7
-3% -$208 ﹤0.01% 6677
2021
Q2
$10K Sell
205
-111
-35% -$6.18K ﹤0.01% 6096
2021
Q1
$23K Buy
316
+278
+732% +$19.7K ﹤0.01% 5397
2020
Q4
$2K Sell
38
-8
-17% -$358 ﹤0.01% 6130
2020
Q3
$2K Buy
46
+38
+475% +$1.96K ﹤0.01% 5914
2020
Q2
$0 Hold
8
﹤0.01% 6401
2020
Q1
$1K Buy
+8
New +$921 ﹤0.01% 5962

Osaic Holdings's ORTX Position: Q1 2024 in Review

Osaic Holdings sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 562 shares — an estimated $9.24K sold.

Osaic Holdings first reported a position in ORTX in Q1 2020 and held it in 16 quarters. The position peaked at $23K in Q1 2021. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

  • Osaic Holdings reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 562 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $9.24K.
  • Osaic Holdings first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2020 and held it in 16 quarters.
  • Osaic Holdings's Orchard Therapeutics plc American Depositary Shares position peaked at $23K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.